Tuesday, July 14, 2020
No menu items!
  • News
  • Blockchain
  • Contact Us
More

    VeChain (VET) Works with a Notable Pharmaceutical Company to Develop Drug-Tracing Platform

    Must Read

    David Schwartz: I Will ‘Almost Certainly’ Buy XRP If Not Involved With Ripple

    The Chief Technical Officer at Ripple, David Schwartz, has recently claimed that he would buy the digital token XRP...

    Analyst That Called Crypto Price Plummet Says Bitcoin (BTC) Price Will Dip To $1000

    A cryptocurrency analyst that accurately forecasted the significant price plummet of Bitcoin (BTC) and other cryptocurrencies has once again...

    Dogecoin Can Achieve Instant Transfer for Micropayments than Many Top Cryptos –OKEx CEO Jay Hao

    Jay Hao, the CEO of OKEx exchange, has claimed that the digital token created out of meme, Dogecoin (DOGE)...
    Tobi Loba
    Tobi Loba
    Tobi-Loba is a creative and an award-winning writer with over 5 million readers from all over the world. She has B.A in English and Literature from a reputable University and currently studying for her M.A in the same field. She recently became a contributor at Herald Sheets in order to fulfill her thirst in reporting crypto and blockchain occurrences, the interest she built over the years.




    VeChain (VET) is collaborating with one of the largest pharmaceutical companies in the world to build a new drug-tracing platform powered by blockchain.

    This new development was revealed by Bayer China in a recent interview. The new innovation is targeted at tracking clinical drugs across the supply chain.

    The drug-tracing platform is known as “CSecure”. The system works by loading a batch number relating to a specific drug, onto the blockchain. Drugs can be tracked individually as it moves across the supply chain with the aid of timestamps and user-identification information.

    Due to the fact that blockchain is immutable in nature, no third party is liable to change the data without permission.

    Back in 2019, VeChain won the right to work with Bayer China, after the firm proposed the implementation of a blockchain-based supply chain solution that was eventually named CSecure.

    The system is based on a proprietary blockchain-as-a-service (BaaS) system, which enables VeChain to build full distributed ledger technology (DLT) solutions to customers’ requirements.

    Prior to this recent partnership with Bayer China, Vechain had sealed a host of big collaborations, such as partnerships with the Chinese arm of supermarket chain Walmart and Big Four accountancy firm PwC.

    Howbeit, at the moment, VeChain has little to say about the latest deal with Bayer China, because the firm is bound by a non-disclosure agreement (NDA), which deters VeChain from disclosing detailed information regarding how CSecure would work.

    Sunny Lu, the co-founder and CEO of VeChain (VET) in a statement expressed his gratitude with the opportunity given to the blockchain project in testing the new drug-tracing product.

    He said,

    “We’ve experienced the rigorousness of the medical industry by working with Bayer China, I feel Bayer’s professionalism and superb work ethic towards medicine and healthcare causes as a whole.”




    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Latest News

    David Schwartz: I Will ‘Almost Certainly’ Buy XRP If Not Involved With Ripple

    The Chief Technical Officer at Ripple, David Schwartz, has recently claimed that he would buy the digital token XRP...

    Analyst That Called Crypto Price Plummet Says Bitcoin (BTC) Price Will Dip To $1000

    A cryptocurrency analyst that accurately forecasted the significant price plummet of Bitcoin (BTC) and other cryptocurrencies has once again predicted that BTC will retest...

    Dogecoin Can Achieve Instant Transfer for Micropayments than Many Top Cryptos –OKEx CEO Jay Hao

    Jay Hao, the CEO of OKEx exchange, has claimed that the digital token created out of meme, Dogecoin (DOGE) has enjoyed development, longevity, and...

    Ripple Commits $50M in Partnership with Top Universities to Accelerate Technical Development in Digital Payments

    Ripple, the cross-border payment firm, is collaborating with top universities around the world to support and accelerate academic research, technical development and innovation in...

    Former Goldman Sachs Hedge Fund Manager Says Ethereum (ETH) Would Lead the Next Breakout

    Raoul Pal, former Goldman Sachs hedge fund manager, has said that Ethereum, the second-largest cryptocurrency by market capitalization could lead the next breakout for...

    More Articles Like This